Abnormal overnight dexamethasone suppression test in subjects receiving rifampicin therapy.
We have studied the effects of rifampicin on the overnight 1-mg dexamethasone suppression test usually employed to exclude suspected Cushing's syndrome. Previous observations indicate that in humans, rifampicin profoundly attenuates the biological effects of hydrocortisol and prednisolone, probably by increasing the metabolism of these drugs in the liver. The study was carried out in 16 normal volunteers. All subjects had a normal overnight 1-mg dexamethasone suppression test (468 +/- 86 vs. 32 +/- 21 nmol/L; mean +/- SD). In 8 subjects treated with rifampicin (600 mg) for 10 days, the inhibitory effect of dexamethasone on serum cortisol was completely prevented (575 +/- 114 vs. 434 +/- 82). In the remaining 8 rifampicin-treated subjects, the inhibitory effect of 1, 2, or 3 mg dexamethasone on serum cortisol was not observed. When 4 mg dexamethasone were administered, the serum cortisol level was 193 nmol/L, above the expected normal suppression value. The plasma dexamethasone concentration was very low after rifampicin treatment (range, 1.2-4.8 nmol/L). We conclude that when patients are treated with rifampicin, the standard overnight dexamethasone suppression test not only has no diagnostic value, but can be very misleading.
Kyriazopoulou
V
V
Department of Medicine, University of Patras Medical School, Rion Patras, Greece.
Vagenakis
A G
AG
D000328:Adult; D003480:Cushing Syndrome / Q000175:diagnosis; D003907:Dexamethasone / Q000097:blood; D003951:Diagnostic Errors; D005189:False Positive Reactions; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D008297:Male; D008875:Middle Aged; D012293:Rifampin / Q000627:therapeutic use*
D003907:Dexamethasone; D012293:Rifampin; D006854:Hydrocortisone